SEQUENTIAL INNATE AND ADAPTIVE IMMUNE MODULATION FOR CANCER TREATMENT

The invention relates to the use of TLR9 agonists, and checkpoint modulators in biomarker-led treatment protocols designed to deliver optimal immune modulation signals to cancer patients following an induction chemotherapy treatment with a chemotherapeutic drug.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JÄHNIG, Peter, LÖHR, Janine, WITTIG, Burghardt
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the use of TLR9 agonists, and checkpoint modulators in biomarker-led treatment protocols designed to deliver optimal immune modulation signals to cancer patients following an induction chemotherapy treatment with a chemotherapeutic drug.